Onderzoeker
Lut Lynen
- Trefwoorden:B510-infecties
Affiliaties
- Instituut voor Tropische Geneeskunde (Onderzoeksinstituut)
Lid
Vanaf1 jan 2001 → Heden - Hiv en Tuberculose (Onderzoekseenheid)
Lid
Vanaf1 jan 2003 → 1 okt 2011 - ITG-DRC-dienst (Onderzoekseenheid)
Lid
Vanaf1 jan 2001 → 4 mei 2023 - Hiv en Tuberculose (Onderzoekseenheid)
Lid
Vanaf1 jan 2001 → 11 mei 2022
Projecten
1 - 10 of 23
- Drug resistant tuberculosis: optimize the composition of new treatment regimens in VietnamVanaf1 jan 2023 → Heden
- Impact of diagnostic delays and short treatment regimens on outcomes of rifampicin-resistant tuberculosis patients in CameroonVanaf1 jan 2022 → Heden
- TB/NTM OnderzoeksclusterVanaf1 jan 2022 → Heden
- Nontuberculous mycobacteria pulmonary disease and tuberculosis-nontuberculous mycobacteria co-infection: Epidemiology, diagnosis, and management at a tertiary health facility in GhanaVanaf1 jan 2022 → Heden
- Alternative methodological approaches to assess longterm HIV virological and clinical outcomes in resource limited settingsVanaf27 apr 2021 → Heden
- Building capacity for research on febrile illness in children and adults in DRCVanaf1 mrt 2021 → 31 dec 2023
- Performance of community-based ART programmes for key populations in Nigeria and sub-Saharan AfricaVanaf1 jan 2021 → Heden
- Statistical methods to guide clinical decision making in TBVanaf1 apr 2020 → Heden
- Community-based tuberculosis triage testing after symptom screening in hard-to-reach African populations: CAD4TB versus C-reactive proteinVanaf1 jan 2020 → 31 dec 2023
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without Creating MoreVanaf1 okt 2018 → Heden
Publicaties
41 - 50 van 208
- Rifampicin-resistant tuberculosis treatment: way forward without hampering future options?(2021)
Auteurs: Tom Decroo, Anita Mesic, Bouke de Jong, L Rigouts, Tinne Gils, J. Mallick, Lutgarde Lynen
Pagina's: 255-255 - Diagnostic accuracy of the INSHI consensus case definition for the diagnosis of paradoxical tuberculosis-IRIS(2021)
Auteurs: Cari Stek, Jozefien Buyze, Joris Menten, Charlotte Schutz, Friedrich Thienemann, Lisette Blumenthal, Gary Maartens, Tom H Boyles, Robert J Wilkinson, Graeme Meintjes, et al.
Pagina's: 587-592 - Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis(2021)
Auteurs: Anita Mesic, Alexander Spina, Htay Thet Mar, Phone Thit, Tom Decroo, Annick Lenglet, Moe Pyae Thandar, Thin Thin Thwe, Aung Aung Kyaw, Tobias Homan, et al.
- High-dose first-line treatment regimen for recurrent rifampicin-susceptible tuberculosis(2020)
Auteurs: Tom Decroo, Bouke de Jong, Alberto Piubello, Mahamadou Bassirou Souleymane, Lutgarde Lynen, A Van Deun
Pagina's: 1578-1579 - First-line tuberculosis treatment with double-dose rifampicin is well tolerated(2020)
Auteurs: A.K.J. Maug, M.A. Hossain, M Gumusboga, Tom Decroo, W Mulders, Sofie Braet, Jozefien Buyze, Diana Arango, Céline Schurmans, Natacha Herssens, et al.
Pagina's: 499-505 - Decision-making in the diagnosis of tuberculous meningitis(2020)
Auteurs: Tom H Boyles, Lut Lynen, James A Seddon
- False rifampicin resistance in Xpert Ultra applied to lymph node aspirate: a case report(2020)
Auteurs: Kamela Charmaine Sy Ng, L Rigouts, Bouke de Jong, Lutgarde Lynen
- Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: a retrospective cohort stud(2020)
Auteurs: Souleymane Hassane-Harouna, Gba-Foromo Cherif, Nimer Ortuno-Gutierrez, Diao Cisse, Lansana Mady Camara, Boubacar Djelo Diallo, Souleymane Camara, Adama Marie Bangoura, Lutgarde Lynen, Tom Decroo
- Challenges to differentiate hepatitis C genotype 1 and 6: results from a field study in Cambodia(2020)
Auteurs: Anja De Weggheleire, Irith De Baetselier, Sokkab An, Sylvie Goletti, Vanessa Suin, Sopheak Thai, Sven Francque, Tania Crucitti, Lut Lynen, Steven Van Gucht, et al.
Pagina's: 657-667 - The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance(2020)
Auteurs: Armand Van Deun, Tom Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, Murid Gumusboga, W Mulders, Nimer Ortuno-Gutierrez, Lutgarde Lynen, Bouke de Jong, Hans L. Rieder